Quick Takeaways
- MORGAN STANLEY filed SCHEDULE 13G/A for TREACE MEDICAL CONCEPTS, INC. Common Stock (TMCI).
- Disclosed ownership: 3.4%.
- Date of event: 31 Dec 2024.
MORGAN STANLEY - 31 Dec 2024 SCHEDULE 13G/A Report for TREACE MEDICAL CONCEPTS, INC. Common Stock (TMCI)
- Filing Manager
- MORGAN STANLEY
- Reporting Manager
- Morgan Stanley
- Symbol
- TMCI
- Shares outstanding
- 61,523,794 shares
- Disclosed Ownership
- 2,091,809 shares
- Ownership
- 3.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 03 Feb 2025, 16:38:47 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"MORGAN STANLEY disclosed 3.4% ownership in TREACE MEDICAL CONCEPTS, INC. Common Stock (TMCI) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 03 Feb 2025, 16:38.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 3.4% | 2,091,809 | 0 | 2,074,734 | Christopher O'Hara | Authorized Signatory, Morgan Stanley |